» Articles » PMID: 16963482

Clinical and Molecular Cytogenetic Characterisation of a Newly Recognised Microdeletion Syndrome Involving 2p15-16.1

Overview
Journal J Med Genet
Specialty Genetics
Date 2006 Sep 12
PMID 16963482
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Background: During whole genome microarray-based comparative genomic hybridisation (array CGH) screening of subjects with idiopathic intellectual disability, we identified two unrelated individuals with a similar de novo interstitial microdeletion at 2p15-2p16.1. Both individuals share a similar clinical phenotype including moderate to severe intellectual disability, autism/autistic features, microcephaly, structural brain anomalies including cortical dysplasia/pachygyria, renal anomalies (multicystic kidney, hydronephrosis), digital camptodactyly, visual impairment, strabismus, neuromotor deficits, communication and attention impairments, and a distinctive pattern of craniofacial features. Dysmorphic craniofacial features include progressive microcephaly, flat occiput, widened inner canthal distance, small palpebral fissures, ptosis, long and straight eyelashes, broad and high nasal root extending to a widened, prominent nasal tip with elongated, smooth philtrum, rounding of the upper vermillion border and everted lower lips.

Methods: Clinical assessments, and cytogenetic, array CGH and fluorescence in situ hybridisation (FISH) analyses were performed.

Results: The microdeletions discovered in each individual measured 4.5 Mb and 5.7 Mb, spanning the chromosome 2p region from 57.2 to 61.7 Mb and from 56 to 61.7 Mb, respectively. Each deleted clone in this range demonstrated a dosage reduction from two to one copy in each proband except for clone RP11-79K21, which was present in three copies in each proband and in four copies in their respective parents (two per each chromosome 2 homologue).

Discussion: The common constellation of features found in the two affected subjects indicates that they have a newly recognised microdeletion syndrome involving haploinsufficiency of one or more genes deleted within at least a 4.5-Mb segment of the 2p15-16.1 region.

Citing Articles

Rare Case of 2p15 Microdeletion Syndrome with Deletion Covering and Genes Diagnosed in a Child - A Case Report.

Reka G, Wojciechowska K, Lejman M Appl Clin Genet. 2024; 17:117-124.

PMID: 39050773 PMC: 11268518. DOI: 10.2147/TACG.S465575.


The Role of Bcl11 Transcription Factors in Neurodevelopmental Disorders.

Seigfried F, Britsch S Biology (Basel). 2024; 13(2).

PMID: 38392344 PMC: 10886639. DOI: 10.3390/biology13020126.


Trait - driven analysis of the 2p15p16.1 microdeletion syndrome suggests a complex pattern of interactions between candidate genes.

Miceli M, Failla P, Saccuzzo L, Galesi O, Amata S, Romano C Genes Genomics. 2023; 45(4):491-505.

PMID: 36807877 PMC: 10027778. DOI: 10.1007/s13258-023-01369-7.


A Japanese boy with double diagnoses of 2p15p16.1 microdeletion syndrome and RP2-associated retinal disorder.

Yamazawa K, Shimizu K, Ohashi H, Haruna H, Inoue S, Murakami H Hum Genome Var. 2021; 8(1):46.

PMID: 34921139 PMC: 8683409. DOI: 10.1038/s41439-021-00178-2.


A Novel de novo Frameshift Mutation in the Gene in a Patient with Intellectual Disability Syndrome and Epilepsy.

Korenke G, Schulte B, Biskup S, Neidhardt J, Owczarek-Lipska M Mol Syndromol. 2020; 11(3):135-140.

PMID: 32903878 PMC: 7445578. DOI: 10.1159/000508566.


References
1.
Dijkman R, Tensen C, Jordanova E, Knijnenburg J, Hoefnagel J, Mulder A . Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. J Clin Oncol. 2005; 24(2):296-305. DOI: 10.1200/JCO.2005.02.0842. View

2.
Flint J, Wilkie A, Buckle V, Winter R, Holland A, McDermid H . The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet. 1995; 9(2):132-40. DOI: 10.1038/ng0295-132. View

3.
Aldred M, Sanford R, Thomas N, Barrow M, Wilson L, Brueton L . Molecular analysis of 20 patients with 2q37.3 monosomy: definition of minimum deletion intervals for key phenotypes. J Med Genet. 2004; 41(6):433-9. PMC: 1735790. DOI: 10.1136/jmg.2003.017202. View

4.
Moser H . Molecular genetics of peroxisomal disorders. Front Biosci. 2000; 5:D298-306. DOI: 10.2741/moser. View

5.
Gohlke B, Haug K, Fukami M, Friedl W, Noeker M, Rappold G . Interstitial deletion in Xp22.3 is associated with X linked ichthyosis, mental retardation, and epilepsy. J Med Genet. 2000; 37(8):600-2. PMC: 1734650. DOI: 10.1136/jmg.37.8.600. View